Financhill
Back

Oramed Pharmaceuticals Quote, Financials, Valuation and Earnings

Oramed Pharmaceuticals Price Quote

$2.47
+0.01 (+7.39%)
(Updated: April 27, 2024 at 6:15 AM ET)

Oramed Pharmaceuticals Key Stats

Sell
39
Oramed Pharmaceuticals (ORMP) is a Sell

Day range:
$2.31 - $2.48
52-week range:
$1.67 - $5.25
Dividend yield:
0%
P/E ratio:
17.57
P/S ratio:
36.91
P/B ratio:
0.61%

Volume:
84.4K
Avg. volume:
114.3K
1-year change:
10.31%
Market cap:
$99.7M
Revenue:
$1.3M
EPS:
$0.14

How Much Does Oramed Pharmaceuticals Make?

Data Unavailable

Is Oramed Pharmaceuticals Growing As A Company?

Data Unavailable

Oramed Pharmaceuticals Stock Price Performance

What Is Oramed Pharmaceuticals 52-Week High & Low?

Oramed Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Oramed Pharmaceuticals?

Is Oramed Pharmaceuticals Cash Flow Positive?

  • What Is ORMP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$10.3M
  • What Is Oramed Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $52M
  • What Is Oramed Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$73M

Oramed Pharmaceuticals Return On Invested Capital

Data Unavailable

Oramed Pharmaceuticals Earnings Date & Stock Price

Oramed Pharmaceuticals Competitors

Oramed Pharmaceuticals Dividend Yield

Data Unavailable

Oramed Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 3400%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 4.25
Upside from Last Price: 72.76%

Major Shareholders

  • How many ORMP shares are owned by institutional investors?
    5.1M ORMP shares are owned by institutional investors
  • How many ORMP shares are owned by insiders?
    20.4M ORMP shares are owned by insiders